Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AMLX |
---|---|---|
09:32 ET | 9312 | 2.95 |
09:34 ET | 8660 | 2.925 |
09:36 ET | 2850 | 2.89 |
09:38 ET | 7195 | 2.89 |
09:39 ET | 2049 | 2.895 |
09:41 ET | 4047 | 2.875 |
09:43 ET | 12646 | 2.915 |
09:45 ET | 1200 | 2.91 |
09:48 ET | 200 | 2.915 |
09:50 ET | 3424 | 2.935 |
09:52 ET | 1000 | 2.94 |
09:54 ET | 4100 | 2.935 |
09:56 ET | 900 | 2.945 |
09:57 ET | 6597 | 2.925 |
09:59 ET | 2155 | 2.924 |
10:01 ET | 2280 | 2.925 |
10:03 ET | 7728 | 2.91 |
10:06 ET | 2886 | 2.915 |
10:08 ET | 100 | 2.915 |
10:10 ET | 915 | 2.911 |
10:12 ET | 27635 | 2.97 |
10:14 ET | 585 | 2.965 |
10:15 ET | 2184 | 2.97 |
10:17 ET | 20158 | 3.0097 |
10:19 ET | 12382 | 3.015 |
10:21 ET | 14105 | 2.995 |
10:24 ET | 5159 | 2.985 |
10:26 ET | 800 | 2.985 |
10:28 ET | 5840 | 3 |
10:30 ET | 19915 | 2.96 |
10:32 ET | 1300 | 2.965 |
10:33 ET | 938 | 2.9561 |
10:35 ET | 1100 | 2.9679 |
10:37 ET | 1343 | 2.965 |
10:39 ET | 400 | 2.97 |
10:42 ET | 21449 | 2.975 |
10:44 ET | 10179 | 2.97 |
10:46 ET | 4877 | 2.989 |
10:48 ET | 1100 | 2.98 |
10:50 ET | 5505 | 3.01 |
10:51 ET | 4613 | 3.0007 |
10:53 ET | 31283 | 2.99 |
10:55 ET | 4825 | 3 |
10:57 ET | 3639 | 3 |
11:00 ET | 2032 | 2.9984 |
11:02 ET | 2354 | 2.985 |
11:04 ET | 8446 | 2.99 |
11:06 ET | 3298 | 2.995 |
11:08 ET | 600 | 2.99 |
11:11 ET | 1841 | 2.99 |
11:13 ET | 300 | 2.9916 |
11:15 ET | 100 | 2.995 |
11:18 ET | 622 | 3 |
11:20 ET | 2084 | 3.01 |
11:22 ET | 1451 | 3.0011 |
11:24 ET | 100 | 3.005 |
11:26 ET | 3200 | 3.01 |
11:27 ET | 3543 | 3.025 |
11:29 ET | 11191 | 3.005 |
11:31 ET | 4977 | 3.01 |
11:33 ET | 9485 | 3.0289 |
11:36 ET | 743 | 3.025 |
11:38 ET | 1675 | 3.025 |
11:40 ET | 14941 | 2.99 |
11:42 ET | 3373 | 2.995 |
11:44 ET | 1598 | 3 |
11:47 ET | 1364 | 2.995 |
11:49 ET | 3300 | 3.005 |
11:51 ET | 625 | 3.005 |
11:54 ET | 1300 | 3.01 |
11:56 ET | 1150 | 3.01 |
11:58 ET | 1058 | 3.014 |
12:00 ET | 5143 | 3 |
12:02 ET | 1108 | 2.9912 |
12:03 ET | 1400 | 2.999 |
12:05 ET | 200 | 2.9989 |
12:07 ET | 906 | 3.005 |
12:09 ET | 3160 | 3.0085 |
12:12 ET | 300 | 3.005 |
12:14 ET | 300 | 3.005 |
12:16 ET | 2773 | 3.01 |
12:18 ET | 2504 | 3 |
12:20 ET | 300 | 2.995 |
12:21 ET | 5100 | 2.995 |
12:23 ET | 550 | 2.995 |
12:25 ET | 20082 | 3 |
12:27 ET | 200 | 2.995 |
12:30 ET | 2465 | 2.985 |
12:32 ET | 14802 | 2.98 |
12:34 ET | 2357 | 2.98 |
12:36 ET | 1200 | 2.98 |
12:38 ET | 830 | 2.98 |
12:39 ET | 753 | 2.985 |
12:41 ET | 1200 | 2.985 |
12:43 ET | 279 | 2.9811 |
12:45 ET | 100 | 2.985 |
12:48 ET | 300 | 2.985 |
12:50 ET | 672 | 2.985 |
12:52 ET | 100 | 2.985 |
12:54 ET | 591 | 2.99 |
12:56 ET | 10384 | 2.99 |
12:57 ET | 1686 | 2.985 |
12:59 ET | 425 | 2.9847 |
01:01 ET | 1213 | 3 |
01:03 ET | 666 | 2.9963 |
01:06 ET | 6185 | 2.984 |
01:08 ET | 1505 | 2.985 |
01:10 ET | 400 | 2.99 |
01:12 ET | 2043 | 2.985 |
01:14 ET | 1696 | 2.985 |
01:15 ET | 200 | 2.985 |
01:17 ET | 2244 | 2.985 |
01:19 ET | 4000 | 2.9863 |
01:21 ET | 1749 | 2.985 |
01:24 ET | 6076 | 3.005 |
01:26 ET | 635 | 3.005 |
01:30 ET | 3156 | 2.99 |
01:32 ET | 4203 | 2.975 |
01:33 ET | 100 | 2.975 |
01:35 ET | 904 | 2.985 |
01:37 ET | 600 | 2.985 |
01:39 ET | 7000 | 2.98 |
01:42 ET | 300 | 2.975 |
01:44 ET | 500 | 2.975 |
01:46 ET | 1500 | 2.97 |
01:48 ET | 1907 | 2.965 |
01:50 ET | 2600 | 2.965 |
01:51 ET | 200 | 2.965 |
01:53 ET | 810 | 2.965 |
01:57 ET | 800 | 2.965 |
02:00 ET | 600 | 2.965 |
02:02 ET | 278 | 2.965 |
02:04 ET | 100 | 2.965 |
02:06 ET | 756 | 2.965 |
02:08 ET | 100 | 2.965 |
02:09 ET | 805 | 2.9611 |
02:11 ET | 12160 | 2.9501 |
02:13 ET | 800 | 2.955 |
02:15 ET | 1225 | 2.955 |
02:18 ET | 1423 | 2.95 |
02:20 ET | 100 | 2.945 |
02:22 ET | 3700 | 2.955 |
02:24 ET | 1115 | 2.955 |
02:26 ET | 719 | 2.96 |
02:29 ET | 175 | 2.955 |
02:31 ET | 285 | 2.95 |
02:33 ET | 1683 | 2.955 |
02:36 ET | 4205 | 2.965 |
02:38 ET | 1699 | 2.955 |
02:40 ET | 150 | 2.955 |
02:42 ET | 1699 | 2.965 |
02:44 ET | 1500 | 2.96 |
02:45 ET | 6236 | 2.96 |
02:47 ET | 1800 | 2.955 |
02:49 ET | 1200 | 2.96 |
02:51 ET | 4316 | 2.95 |
02:54 ET | 1700 | 2.945 |
02:56 ET | 400 | 2.945 |
02:58 ET | 1129 | 2.95 |
03:00 ET | 13378 | 2.9399 |
03:02 ET | 5040 | 2.945 |
03:03 ET | 1100 | 2.945 |
03:05 ET | 3177 | 2.965 |
03:07 ET | 6436 | 2.955 |
03:09 ET | 353 | 2.955 |
03:12 ET | 800 | 2.96 |
03:14 ET | 2614 | 2.95 |
03:16 ET | 4908 | 2.95 |
03:18 ET | 2335 | 2.94 |
03:20 ET | 9330 | 2.945 |
03:21 ET | 2735 | 2.935 |
03:23 ET | 11848 | 2.955 |
03:25 ET | 2718 | 2.955 |
03:27 ET | 309 | 2.96 |
03:30 ET | 2600 | 2.965 |
03:32 ET | 2600 | 2.96 |
03:36 ET | 5643 | 2.955 |
03:38 ET | 6369 | 2.945 |
03:39 ET | 3097 | 2.955 |
03:41 ET | 200 | 2.955 |
03:43 ET | 2100 | 2.965 |
03:45 ET | 1936 | 2.96 |
03:48 ET | 200 | 2.9678 |
03:50 ET | 600 | 2.97 |
03:52 ET | 6770 | 2.99 |
03:54 ET | 1100 | 2.985 |
03:56 ET | 7904 | 2.985 |
03:57 ET | 36919 | 3 |
03:59 ET | 406325 | 3.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Amylyx Pharmaceuticals Inc | 204.9M | -1.2x | --- |
Amarin Corporation PLC | 239.6M | -7.1x | --- |
Organogenesis Holdings Inc | 385.8M | -23.3x | --- |
Ironwood Pharmaceuticals Inc | 642.2M | 93.0x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Coherus BioSciences Inc | 115.2M | -2.5x | --- |
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $204.9M |
---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.